RIPK1 suppresses a TRAF2-dependent pathway to liver cancer
Summary. Receptor-interacting protein kinase 1 (RIPK1) represents an essential signaling node in cell death and inflammation. Ablation of Ripk1 in liver parenchymal cells (LPC) did not cause a spontaneous phenotype, but led to tumor necrosis factor (TNF)-dependent hepatocyte apoptosis and liver inju...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017
|
| In: |
Cancer cell
Year: 2016, Volume: 31, Issue: 1, Pages: 94-109 |
| ISSN: | 1878-3686 |
| DOI: | 10.1016/j.ccell.2016.11.009 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1016/j.ccell.2016.11.009 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1535610816305529 
|
| Author Notes: | Anne T. Schneider, Jérémie Gautheron, Maria Feoktistova, Christoph Roderburg, Sven H. Loosen, Sanchari Roy, Fabian Benz, Peter Schemmer, Markus W. Büchler, Ueli Nachbur, Ulf P. Neumann, Rene Tolba, Mark Luedde, Jessica Zucman-Rossi, Diana Panayotova-Dimitrova, Martin Leverkus, Christian Preisinger, Frank Tacke, Christian Trautwein, Thomas Longerich, Mihael Vucur, and Tom Luedde |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1576820939 | ||
| 003 | DE-627 | ||
| 005 | 20220814173625.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180625r20172016xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ccell.2016.11.009 |2 doi | |
| 035 | |a (DE-627)1576820939 | ||
| 035 | |a (DE-576)506820939 | ||
| 035 | |a (DE-599)BSZ506820939 | ||
| 035 | |a (OCoLC)1341012380 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schneider, Anne Theres |e VerfasserIn |0 (DE-588)1155725603 |0 (DE-627)1017918406 |0 (DE-576)501811621 |4 aut | |
| 245 | 1 | 0 | |a RIPK1 suppresses a TRAF2-dependent pathway to liver cancer |c Anne T. Schneider, Jérémie Gautheron, Maria Feoktistova, Christoph Roderburg, Sven H. Loosen, Sanchari Roy, Fabian Benz, Peter Schemmer, Markus W. Büchler, Ueli Nachbur, Ulf P. Neumann, Rene Tolba, Mark Luedde, Jessica Zucman-Rossi, Diana Panayotova-Dimitrova, Martin Leverkus, Christian Preisinger, Frank Tacke, Christian Trautwein, Thomas Longerich, Mihael Vucur, and Tom Luedde |
| 264 | 1 | |c 2017 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published: December 22, 2016 | ||
| 500 | |a Gesehen am 25.06.2016 | ||
| 520 | |a Summary. Receptor-interacting protein kinase 1 (RIPK1) represents an essential signaling node in cell death and inflammation. Ablation of Ripk1 in liver parenchymal cells (LPC) did not cause a spontaneous phenotype, but led to tumor necrosis factor (TNF)-dependent hepatocyte apoptosis and liver injury without affecting inducible nuclear factor κB (NF-κB) activation. Loss of Ripk1 induced the TNF-dependent proteasomal degradation of the E3-ligase, TNF receptor-associated factor 2 (TRAF2), in a kinase-independent manner, thereby activating caspase-8. Moreover, loss of both Ripk1 and Traf2 in LPC not only resulted in caspase-8 hyperactivation but also impaired NF-κB activation, promoting the spontaneous development of hepatocellular carcinoma. In line, low RIPK1 and TRAF2 expression in human HCCs was associated with an unfavorable prognosis, suggesting that RIPK1 collaborates with TRAF2 to inhibit murine and human hepatocarcinogenesis. | ||
| 534 | |c 2016 | ||
| 650 | 4 | |a apoptosis | |
| 650 | 4 | |a caspase-8 | |
| 650 | 4 | |a cIAP-1 | |
| 650 | 4 | |a HCC | |
| 650 | 4 | |a hepatocarcinogenesis | |
| 650 | 4 | |a necroptosis | |
| 650 | 4 | |a NF-κB | |
| 650 | 4 | |a RIP1 | |
| 650 | 4 | |a RIP3 | |
| 650 | 4 | |a RIPK3 | |
| 700 | 1 | |a Schemmer, Peter |d 1967- |e VerfasserIn |0 (DE-588)1022604244 |0 (DE-627)717006794 |0 (DE-576)365668230 |4 aut | |
| 700 | 1 | |a Büchler, Markus W. |d 1955- |e VerfasserIn |0 (DE-588)120893339 |0 (DE-627)080952526 |0 (DE-576)292434146 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer cell |d Cambridge, Mass. : Cell Press, 2002 |g 31(2017), 1, Seite 94-109 |h Online-Ressource |w (DE-627)343970082 |w (DE-600)2074034-7 |w (DE-576)097935972 |x 1878-3686 |7 nnas |a RIPK1 suppresses a TRAF2-dependent pathway to liver cancer |
| 773 | 1 | 8 | |g volume:31 |g year:2017 |g number:1 |g pages:94-109 |g extent:16 |a RIPK1 suppresses a TRAF2-dependent pathway to liver cancer |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ccell.2016.11.009 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1535610816305529 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180625 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 120893339 |a Büchler, Markus W. |m 120893339:Büchler, Markus W. |d 910000 |d 910200 |e 910000PB120893339 |e 910200PB120893339 |k 0/910000/ |k 1/910000/910200/ |p 9 | ||
| 998 | |g 1022604244 |a Schemmer, Peter |m 1022604244:Schemmer, Peter |p 8 | ||
| 999 | |a KXP-PPN1576820939 |e 3013700637 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1576820939","note":["Published: December 22, 2016","Gesehen am 25.06.2016"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"RIPK1 suppresses a TRAF2-dependent pathway to liver cancer","title":"RIPK1 suppresses a TRAF2-dependent pathway to liver cancer"}],"language":["eng"],"person":[{"display":"Schneider, Anne Theres","given":"Anne Theres","roleDisplay":"VerfasserIn","role":"aut","family":"Schneider"},{"display":"Schemmer, Peter","given":"Peter","roleDisplay":"VerfasserIn","role":"aut","family":"Schemmer"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Markus W.","display":"Büchler, Markus W.","family":"Büchler"}],"relHost":[{"title":[{"title_sort":"Cancer cell","title":"Cancer cell"}],"language":["eng"],"disp":"RIPK1 suppresses a TRAF2-dependent pathway to liver cancerCancer cell","physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Cell Press ; Elsevier","dateIssuedDisp":"2002-","dateIssuedKey":"2002","publisherPlace":"Cambridge, Mass. ; New York, NY"}],"id":{"issn":["1878-3686"],"zdb":["2074034-7"],"eki":["343970082"]},"part":{"volume":"31","issue":"1","text":"31(2017), 1, Seite 94-109","pages":"94-109","year":"2017","extent":"16"},"recId":"343970082","note":["Gesehen am 28.02.11"],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2002 -"]}],"id":{"doi":["10.1016/j.ccell.2016.11.009"],"eki":["1576820939"]},"name":{"displayForm":["Anne T. Schneider, Jérémie Gautheron, Maria Feoktistova, Christoph Roderburg, Sven H. Loosen, Sanchari Roy, Fabian Benz, Peter Schemmer, Markus W. Büchler, Ueli Nachbur, Ulf P. Neumann, Rene Tolba, Mark Luedde, Jessica Zucman-Rossi, Diana Panayotova-Dimitrova, Martin Leverkus, Christian Preisinger, Frank Tacke, Christian Trautwein, Thomas Longerich, Mihael Vucur, and Tom Luedde"]},"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"physDesc":[{"extent":"16 S."}]} | ||
| SRT | |a SCHNEIDERARIPK1SUPPR2017 | ||